In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a RITONAVIR AND LOPINAVIR Drug Master File in Korea (RITONAVIR AND LOPINAVIR KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of RITONAVIR AND LOPINAVIR. The MFDS reviews the RITONAVIR AND LOPINAVIR KDMF as part of the drug registration process and uses the information provided in the RITONAVIR AND LOPINAVIR KDMF to evaluate the safety and efficacy of the drug.
After submitting a RITONAVIR AND LOPINAVIR KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their RITONAVIR AND LOPINAVIR API can apply through the Korea Drug Master File (KDMF).
click here to find a list of RITONAVIR AND LOPINAVIR suppliers with KDMF on PharmaCompass.